Fresenius Medical Care (FMS) Competitors

$21.97
-0.42 (-1.88%)
(As of 05/17/2024 08:53 PM ET)

FMS vs. DVA, SHC, INCY, NTRA, RVTY, THC, SRPT, TECH, VTRS, and SWAV

Should you be buying Fresenius Medical Care stock or one of its competitors? The main competitors of Fresenius Medical Care include DaVita (DVA), Sotera Health (SHC), Incyte (INCY), Natera (NTRA), Revvity (RVTY), Tenet Healthcare (THC), Sarepta Therapeutics (SRPT), Bio-Techne (TECH), Viatris (VTRS), and Shockwave Medical (SWAV). These companies are all part of the "medical" sector.

Fresenius Medical Care vs.

DaVita (NYSE:DVA) and Fresenius Medical Care (NYSE:FMS) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, earnings, risk, institutional ownership, valuation, media sentiment, analyst recommendations, dividends and profitability.

DaVita has higher earnings, but lower revenue than Fresenius Medical Care. DaVita is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DaVita$12.14B1.01$691.53M$8.8015.89
Fresenius Medical Care$21.05B0.61$540.07M$0.8924.69

DaVita received 87 more outperform votes than Fresenius Medical Care when rated by MarketBeat users. Likewise, 61.70% of users gave DaVita an outperform vote while only 53.99% of users gave Fresenius Medical Care an outperform vote.

CompanyUnderperformOutperform
DaVitaOutperform Votes
493
61.70%
Underperform Votes
306
38.30%
Fresenius Medical CareOutperform Votes
406
53.99%
Underperform Votes
346
46.01%

90.1% of DaVita shares are held by institutional investors. Comparatively, 8.3% of Fresenius Medical Care shares are held by institutional investors. 1.4% of DaVita shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

DaVita has a beta of 1.04, suggesting that its stock price is 4% more volatile than the S&P 500. Comparatively, Fresenius Medical Care has a beta of 0.95, suggesting that its stock price is 5% less volatile than the S&P 500.

In the previous week, DaVita had 8 more articles in the media than Fresenius Medical Care. MarketBeat recorded 14 mentions for DaVita and 6 mentions for Fresenius Medical Care. DaVita's average media sentiment score of 1.15 beat Fresenius Medical Care's score of 0.75 indicating that Fresenius Medical Care is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
DaVita
6 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Fresenius Medical Care
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

DaVita has a net margin of 6.61% compared to DaVita's net margin of 2.48%. Fresenius Medical Care's return on equity of 68.52% beat DaVita's return on equity.

Company Net Margins Return on Equity Return on Assets
DaVita6.61% 68.52% 4.98%
Fresenius Medical Care 2.48%5.29%2.30%

DaVita presently has a consensus target price of $144.67, indicating a potential upside of 3.47%. Fresenius Medical Care has a consensus target price of $24.00, indicating a potential upside of 9.24%. Given DaVita's higher possible upside, analysts plainly believe Fresenius Medical Care is more favorable than DaVita.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DaVita
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
Fresenius Medical Care
1 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.14

Summary

DaVita beats Fresenius Medical Care on 13 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FMS vs. The Competition

MetricFresenius Medical Carehealth & allied services, not elsewhere classified IndustryMedical SectorNYSE Exchange
Market Cap$12.89B$2.25B$5.37B$18.08B
Dividend Yield1.89%1.89%44.70%3.44%
P/E Ratio24.6917.02139.1326.21
Price / Sales0.615.952,368.3410.64
Price / Cash4.7511.4236.9819.24
Price / Book0.783.155.516.00
Net Income$540.07M$74.19M$106.10M$966.17M
7 Day Performance1.15%-1.56%1.42%1.85%
1 Month Performance12.44%-2.86%4.97%6.59%
1 Year Performance-5.59%-24.28%7.98%23.69%

Fresenius Medical Care Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DVA
DaVita
3.524 of 5 stars
$137.01
+0.3%
$129.75
-5.3%
+39.4%$12.02B$12.14B15.5770,000
SHC
Sotera Health
3.2707 of 5 stars
$11.40
+0.2%
$17.70
+55.3%
-22.9%$3.23B$1.05B60.003,000
INCY
Incyte
4.8857 of 5 stars
$57.05
-1.0%
$74.93
+31.3%
-10.2%$12.93B$3.77B17.292,524
NTRA
Natera
1.0955 of 5 stars
$105.52
+2.1%
$98.47
-6.7%
+109.9%$12.74B$1.08B-33.823,293Analyst Upgrade
Insider Selling
RVTY
Revvity
3.0837 of 5 stars
$106.53
+0.9%
$118.17
+10.9%
-7.4%$13.14B$2.75B88.0411,500Positive News
THC
Tenet Healthcare
4.2438 of 5 stars
$128.53
+1.9%
$113.19
-11.9%
+76.3%$12.55B$20.55B4.99106,500Positive News
SRPT
Sarepta Therapeutics
4.4518 of 5 stars
$132.66
+0.7%
$160.60
+21.1%
-11.9%$12.54B$1.24B1,206.001,314Analyst Forecast
TECH
Bio-Techne
4.2817 of 5 stars
$84.15
+2.7%
$80.50
-4.3%
-0.1%$13.26B$1.14B66.793,050Positive News
VTRS
Viatris
0.6921 of 5 stars
$11.14
-1.9%
$11.00
-1.3%
+17.7%$13.26B$15.43B-185.6738,000
SWAV
Shockwave Medical
4.5013 of 5 stars
$331.00
+0.2%
$309.11
-6.6%
+20.0%$12.43B$730.23M77.341,468Positive News

Related Companies and Tools

This page (NYSE:FMS) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners